Eikon Therapeutics, Inc. (EIKN)
7.26
-0.98
(-11.89%)
USD |
NASDAQ |
Oct 23, 16:00
7.24
-0.02
(-0.28%)
After-Hours: 20:00
Eikon Therapeutics Price to Book Value : 0.8427 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.8427 |
| October 22, 2026 | 0.9565 |
| October 21, 2026 | 0.9286 |
| October 20, 2026 | 0.9495 |
| October 19, 2026 | 0.8938 |
| October 16, 2026 | 0.8613 |
| October 15, 2026 | 0.8752 |
| October 14, 2026 | 0.8137 |
| October 13, 2026 | 0.78 |
| October 12, 2026 | 0.8427 |
| October 09, 2026 | 0.8671 |
| October 08, 2026 | 0.8706 |
| October 07, 2026 | 0.8752 |
| October 06, 2026 | 0.8717 |
| October 05, 2026 | 0.8752 |
| October 02, 2026 | 0.8508 |
| October 01, 2026 | 0.8601 |
| September 30, 2026 | 0.9332 |
| September 29, 2026 | 0.9182 |
| September 28, 2026 | 0.9182 |
| September 25, 2026 | 0.9193 |
| September 24, 2026 | 0.9623 |
| September 23, 2026 | 0.9437 |
| September 22, 2026 | 1.042 |
| September 21, 2026 | 1.025 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.039 |
| September 17, 2026 | 0.9982 |
| September 16, 2026 | 0.9878 |
| September 15, 2026 | 1.102 |
| September 14, 2026 | 1.086 |
| September 11, 2026 | 1.038 |
| September 10, 2026 | 1.069 |
| September 09, 2026 | 1.246 |
| September 08, 2026 | 1.243 |
| September 04, 2026 | 1.261 |
| September 03, 2026 | 1.272 |
| September 02, 2026 | 1.321 |
| September 01, 2026 | 1.263 |
| August 31, 2026 | 1.214 |
| August 28, 2026 | 1.274 |
| August 27, 2026 | 1.337 |
| August 26, 2026 | 1.391 |
| August 25, 2026 | 1.457 |
| August 24, 2026 | 1.295 |
| August 21, 2026 | 1.322 |
| August 20, 2026 | 1.248 |
| August 19, 2026 | 1.394 |
| August 18, 2026 | 1.352 |
| August 17, 2026 | 1.215 |
| August 14, 2026 | 1.283 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| PEG Ratio | -0.008 |
| Price | 7.26 |
| Earnings Yield | -90.63% |
| Market Cap | 393.12M |
| PEGY Ratio | -0.008 |